Same Indication

Pembrolizumab vs Spironolactone

Pembrolizumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Spironolactone.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days; Spironolactone β€” 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone β€” C24H32O4S.

Molecular Weight: Spironolactone β€” 416.5740 g/mol.

Type: Pembrolizumab β€” Antibody; Spironolactone β€” Small molecule.